De Simone, Clara
 Distribuzione geografica
Continente #
NA - Nord America 10.396
AS - Asia 8.379
EU - Europa 7.643
SA - Sud America 1.655
AF - Africa 255
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 11
Totale 28.378
Nazione #
US - Stati Uniti d'America 10.149
SG - Singapore 4.033
DE - Germania 2.549
CN - Cina 1.957
BR - Brasile 1.369
SE - Svezia 1.079
FR - Francia 792
VN - Vietnam 735
IT - Italia 694
UA - Ucraina 606
GB - Regno Unito 416
IE - Irlanda 384
FI - Finlandia 370
ID - Indonesia 261
IN - India 259
JP - Giappone 243
PL - Polonia 185
HK - Hong Kong 181
RU - Federazione Russa 174
CA - Canada 111
TR - Turchia 108
AR - Argentina 105
BD - Bangladesh 103
IQ - Iraq 97
NL - Olanda 70
CI - Costa d'Avorio 68
MX - Messico 68
ZA - Sudafrica 63
BE - Belgio 51
ES - Italia 51
KR - Corea 51
EC - Ecuador 48
AT - Austria 46
SA - Arabia Saudita 43
EG - Egitto 35
JO - Giordania 33
PK - Pakistan 32
VE - Venezuela 32
CO - Colombia 29
IR - Iran 29
AU - Australia 26
PH - Filippine 25
CH - Svizzera 23
CZ - Repubblica Ceca 23
LT - Lituania 23
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
MA - Marocco 21
CL - Cile 20
KE - Kenya 18
MY - Malesia 17
PA - Panama 17
KZ - Kazakistan 16
AZ - Azerbaigian 15
PE - Perù 15
PT - Portogallo 14
PY - Paraguay 14
RO - Romania 14
NZ - Nuova Zelanda 13
IL - Israele 12
AL - Albania 11
BO - Bolivia 11
CR - Costa Rica 11
UY - Uruguay 11
DZ - Algeria 10
TW - Taiwan 10
BG - Bulgaria 9
HN - Honduras 9
OM - Oman 9
DK - Danimarca 8
ET - Etiopia 8
EU - Europa 8
NO - Norvegia 8
NP - Nepal 8
TN - Tunisia 8
JM - Giamaica 7
KG - Kirghizistan 7
NG - Nigeria 7
PS - Palestinian Territory 7
GR - Grecia 6
HR - Croazia 6
HU - Ungheria 6
LB - Libano 6
DO - Repubblica Dominicana 5
TT - Trinidad e Tobago 5
BN - Brunei Darussalam 4
CY - Cipro 4
GT - Guatemala 4
LK - Sri Lanka 4
LU - Lussemburgo 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
GH - Ghana 3
LA - Repubblica Popolare Democratica del Laos 3
ME - Montenegro 3
MK - Macedonia 3
NI - Nicaragua 3
Totale 28.333
Città #
Singapore 2.085
Chandler 1.439
Ashburn 1.112
San Jose 905
Dallas 665
Beijing 396
Dublin 364
Jacksonville 342
San Mateo 296
New York 261
Ho Chi Minh City 257
Lauterbourg 244
Jakarta 235
Nanjing 209
Tokyo 208
Los Angeles 202
Hefei 199
Boston 182
Wilmington 180
Frankfurt am Main 177
Helsinki 170
Ann Arbor 166
Hanoi 162
Hong Kong 158
Woodbridge 157
Munich 142
Milan 136
Houston 134
The Dalles 133
Princeton 132
Dearborn 120
Nürnberg 114
Chicago 111
Rome 111
São Paulo 111
Bremen 105
Moscow 102
Cattolica 94
Redwood City 89
Warsaw 87
Nanchang 85
Paris 79
Kraków 78
Seattle 70
Abidjan 68
Fairfield 68
Santa Clara 66
Marseille 65
Lawrence 64
London 60
Rio de Janeiro 59
Boardman 57
Buffalo 52
Kent 49
Leawood 49
Da Nang 48
Mountain View 48
Detroit 47
Zhengzhou 47
Brussels 46
Izmir 46
Hebei 43
Seoul 43
Turku 43
Hangzhou 41
Brooklyn 40
Redmond 40
Council Bluffs 38
Guangzhou 38
Shenyang 38
Atlanta 37
Baghdad 36
North Bergen 36
St Louis 36
Menlo Park 33
Nuremberg 33
Kunming 32
Lappeenranta 32
Norwalk 32
Shanghai 32
Tianjin 32
Brasília 31
Orem 31
Amman 30
Haiphong 30
University Park 30
Curitiba 29
Johannesburg 29
Toronto 29
Amsterdam 28
Montreal 28
Belo Horizonte 27
Düsseldorf 27
Vienna 27
Jiaxing 26
Poplar 26
Stockholm 26
Denver 25
Dhaka 25
Hyderabad 24
Totale 15.006
Nome #
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C 246
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 245
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 236
Impetigo herpetiformis occurring during N-butyl-scopolammonium bromide therapy in pregnancy: case report 221
Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B 221
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 218
A Suspected Squamous Cell Carcinoma in a Renal Transplant Recipient Revealing a Rare Cutaneous Phaeohyphomycosis by Alternaria infectoria 210
High prevalence of celiac disease in psoriasis 205
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 205
Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF 204
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 204
Malignant melanoma in a tattoo: case report and review of the literature 203
Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature 193
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 192
A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole 185
Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis 184
Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea 180
Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature 178
ENDOTHELIAL DYSFUNCTION IN PSORIASIS PATIENTS: CROSS-SECTIONAL CASE-CONTROL STUDY 177
Cardiomyopathy in scleromyxedema: report of a fatal case. 176
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 172
Non-Herlitz junctional epidermolysis bullosa without hair involvement associated with BP180 deficiency 171
Granulomatous reaction after an aesthetic electroporation procedure 170
Paradoxical skin reactions to biologics in patients with rheumatologic disorders 168
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. 167
Malabsorption in psoriatic patients: cause or consequence? 167
Exacerbation of pemphigus after influenza vaccination. 167
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 167
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 166
Linagliptin-induced bullous pemphigoid 164
Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment 163
Clinical and ultrasonographic profile of adalimumab-treated hidradenitis suppurativa patients: A real-life monocentric experience 163
A suspected squamous cell carcinoma in a renal transplant recipient revealed a rare cutaneous phaeohyphomycosis by Alternaria Infectoria 161
Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study 159
Treatment of Cutaneous Calciphylaxis with Sodium Thiosulfate 158
Huriez syndrome: case report with detailed analysis of skin dendritic cells. 158
Serum beta 2 microglobulin in psoriasis and psoriatic patients 158
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 157
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 156
Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature 156
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients 153
Management of recurrent cutaneous abscesses during therapy with infliximab 152
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 148
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 147
Increased polymorphonuclear leukocyte Fc gamma-dependent chemiluminescence in active psoriasis is not related to FcRIII (CD16) receptor expression 147
Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature 147
Drug-induced hair colour changes 147
Propofol-induced irreversible hair depigmentation: A case report 147
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study 146
Circumscribed pityriasis rubra pilaris type IV 145
[Acne fulminans during therapy with isotretinoin] 143
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 143
Evaluation of Endothelial Dysfunction in Psoriatic Patients by Different Techniques 143
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study 142
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports 140
Treatment of severe psoriasis with somatostatin: four years of experience 139
Lichenoid reaction induced by adalimumab 138
TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients 138
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study 138
A) High prevalence of celiac disease in psoriasis. 137
amyopatic dermatomyositis: a review by the Italian Group of immunodermatology 137
Follicular mucinosis successfully treated with isotretinoin 137
psoriasiform keratosis 136
Complete clinical remission of psoriasis 6 months after renal transplantation 136
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 136
Detection and management of latent tuberculosis infections before biologic therapy for psoriasis 134
Validation and field performance of the Italian version of the psoriatic arthritis screening and evaluation (PASE) questionnaire 134
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 133
The role of immune serological parameters and allergological tests in psoriasis 133
Achilles tendinitis in psoriasis: clinical and sonographic findings 133
Giant verrucous porokeratosis of Mibelli mimicking psoriasis in a patient with psoriasis 133
Cutaneous lupus erythematosus mimicking multiple keratoacanthomas 132
Etanercept therapy for psoriasis in a patient with numerous comorbidities 132
Combination of retinoids and PUVA (Re-PUVA) in the treatment of cutaneous T cell lymphomas 131
Dermatological signs during inflammatory bowel diseases 131
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 129
development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine 128
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 128
Silent acro-osteolysis in a patient with psoriatic disease and recurrent micro-trauma 127
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 126
Dyshidrosiform pemphigoid: a well-defined clinical entity? 125
Psychopathology and eating disorders in patients with psoriasis 125
The treatment of onychomycosis with a new form of tioconazole 124
Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis 124
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 124
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a “real-world”, mono-center experience 123
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 123
Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy 123
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis 122
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 122
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis 121
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients 121
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 121
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
urocanic acid isomers in patients with non-melanma skin cancer 120
Effect of adherence to plastic on peripheral blood monocyte and alveolar macrophage chemiluminescence 120
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 119
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 119
Pruritus characteristics in a large Italian cohort of psoriatic patients 119
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data. 117
Totale 15.309
Categoria #
all - tutte 115.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 0 0 0 0 38 215 41
2021/20221.514 95 142 22 66 82 43 31 246 49 104 295 339
2022/20233.931 473 515 294 586 284 500 173 322 499 81 140 64
2023/20241.971 87 540 60 281 72 215 94 73 27 77 235 210
2024/20254.204 119 121 330 141 346 226 111 196 684 353 885 692
2025/202610.854 1.703 321 1.190 1.224 1.860 560 1.994 558 707 737 0 0
Totale 28.688